title: Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
authors.affiliation: gary.evans@ahcpub.com
authors.forename: Gary
authors.initials: G
authors.lastname: Evans
mesh_terms: D000881:Anthrax / Q000188:drug therapy*; D022122:Anthrax Vaccines / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D023482:Bioterrorism; D002487:Centers for Disease Control and Prevention, U.S.; D006801:Humans; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D014481:United States
chemical_list: D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents